Nurix

Nurix

Develops small molecule inhibitors for the treatment of proliferative and degenerative diseases
San Francisco United States (HQ)

Nurix Company information

Edit
Date
Employees
108 people
Ownership
Firm valuation
€436—655m (Dealroom.co estimates Mar 2020.)
  • Edit
DateInvestorsAmountRound
$3.1mSEED
$25.1mSERIES B
N/A$17mSERIES C
*
$120mLATE VC
Total Funding€150m

Recent News about Nurix

Edit
LocationEdit
1700 Owens St, San Francisco, CA 94158, USA
Are you an employee or an investor of this company?
Add your profile